For this reason, it is important that effective mechanisms for disseminating new research findings are adopted because if mutations in BRCA1 or BRCA2 can be identified and at-risk relatives are able to adopt preventive measures, the incidence of ovarian cancer may be reduced. This evidence concerns the gene BRCA1 and ovarian carcinoma.